Item 7.01 Regulation FD Disclosure.

On November 9, 2022, Focus Draw Group Limited and DragonCloud Technology Limited (collectively, the "Selling Stockholders") completed the sales of an aggregate amount of 4,728,000 shares and 5,768,100 shares, respectively, of Class A Common Stock, par value $0.001 per share ("Common Stock"), of Yubo International Biotech Limited, a New York corporation (the "Company"), as selling stockholders in a registered offering of the Company (the "Offering"). The shares of Common Stock were sold by the Selling Stockholders at $0.50 per share to certain non-affiliates of the Company, pursuant to the Stock Purchase Agreements, dated as of September 23, 2022, each entered into by and among the applicable Selling Stockholder, the Company, and the applicable non-affiliate purchaser. The Company did not receive any of the proceeds from the sales of Common Stock sold by the Selling Stockholders in the Offering.

The Offering was registered pursuant to a registration statement on Form S-1 (File No. 333-255805), including all amendments thereto, the exhibits and any schedules thereto, the documents, otherwise deemed to be part thereof or included therein (the "Registration Statement") filed with the U.S. Securities and Exchange Commission (the "SEC"), which was declared effective by the SEC on July 29, 2022.




Item 8.01 Other Events.

The information in Item 7.01 above is incorporated herein by reference in this Item 8.01.

The information contained in Item 7.01 above and this Item 8.01 and the exhibits hereto shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and shall not be incorporated by reference into any filings made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as may be expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.





(d) Exhibits.



Exhibit No.                                Description
  99.1*         Stock Purchase Agreement, dated September 23, 2022, by and among
              Focus Draw Group Limited, Yubo International Biotech Limited and World
              Precision Medicine Technology Limited
  99.2*         Stock Purchase Agreement, dated September 23, 2022, by and among
              Focus Draw Group Limited, Yubo International Biotech Limited and Xu
              Xiuqun
  99.3*         Stock Purchase Agreement, dated September 23, 2022, by and among
              DragonCloud Technology Limited, Yubo International Biotech Limited and
              Xu Xiuqun
  99.4*         Stock Purchase Agreement, dated September 23, 2022, by and among
              DragonCloud Technology Limited, Yubo International Biotech Limited and
              Sun Weitao
104           Cover Page Interactive Data File (embedded within the Inline XBRL
              document)

* Certain portions of this exhibit have been redacted to remove personally identifiable information.






2

© Edgar Online, source Glimpses